Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306

BACKGROUND: Tumor assessments after first-line therapy of RAS wild-type mCRC with cetuximab (cet) versus bevacizumab (bev) in combination with FOLFIRI were evaluated for factors influencing resectability, conversion to resectability, and survival after best response. METHODS: Conversion to resectabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Modest, Dominik Paul, Heinemann, Volker, Folprecht, Gunnar, Denecke, Timm, Pratschke, Johann, Lang, Hauke, Bemelmans, Marc, Becker, Thomas, Rentsch, Markus, Seehofer, Daniel, Bruns, Christiane J., Gebauer, Bernhard, Held, Swantje, Stahler, Arndt, Heinrich, Kathrin, von Einem, Jobst C., Stintzing, Sebastian, Neumann, Ulf P., Ricard, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Hepatobiliary Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311511/
https://www.ncbi.nlm.nih.gov/pubmed/32172334
http://dx.doi.org/10.1245/s10434-020-08219-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311511/
https://www.ncbi.nlm.nih.gov/pubmed/32172334
http://dx.doi.org/10.1245/s10434-020-08219-w

Ejemplares similares